drugset / Trial / NCT00538564

Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

NCT00538564 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This research is being done to compare the effect of tadalafil with placebo (an inactive substance that looks like the study drug, but should have no effect) on the frequency of recurrent priapism (prolonged erection, unassociated with sexual interest or desire) and the nature of sexual experiences in male patients with sickle cell disease.

Timeline

Start
2006-11
Primary completion
2009-08
Completion
2009-08

Outcome

Outcome not reported

Stopped: “Trial closed just prior to study receiving Investigational Review Board approval”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 10 mg Oral